Premium
What If?
Author(s) -
Darlene R Hess
Publication year - 1998
Publication title -
seminars in dialysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 78
eISSN - 1525-139X
pISSN - 0894-0959
DOI - 10.1111/j.1525-139x.1998.tb00307.x
Subject(s) - citation , medicine , information retrieval , library science , computer science
13. Eschhach JW, Ahdulhadi MH, Browne JK, Nissenson AR, et al.: Recombinant human erythropoietin in anemic patients with end-stage renal disease: Results of a Phase 111. multicenter clinical trial. Ann Infern Med 1119921000, 1989 14. Nissenson AR: National cooperative rHu erythropoietin study in patients with chronic renal failure: A phase IV multicenter study. Am J Kidnev Dis 18(4)(Suppl 1):?4-33, 1991 IS. Marsh JT. Brown WS, Wolcott DL, Carr CR, Higa J, Schweitzer SU. Nissenson A R rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney Inr 39:15.5-163. 1991 16. Wolcott DL, Marsh JT. La Rue A, Cam C, Nissenson AR: Recombinant human erythropoietin (rHuEPO) treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis 14: 478485. 1989 17. Nissenson AR, Pickett JL. Theherge DC, Brown WS. Schweitzer SU: Brain function is better in hemodialysis patients when hematocrit is normalized with erythropoietin. [Abstract] 29th Aiimal Meeting ofthe American Sociev of NephTology 7:1459. 1996 18. Nissenson AR, Swan S. Lamhrecht LL, Anderson P, Schweitzer SU: Ferric gluconate is safe in hemodialysis patients who react to iron dextran. [Ahstract] 29th Annual Meeting of the Ainerican Society of Nephrology 1:1460, 1996 19. Nissenson AR, Lindsay RM, Swan S , Lamhrecht LL, et al.: Ferric gluconate (Ferrlecit) is safe and effective in heniodialysis patients: North American Trial. [Abstract] 29th Annnal Meeting cfthe American Society uf'Nephrolog>r 7:1459, 1996 20. Kjellstrand CM: The search for scientific truth versus corporate interests. Semin Dial 6:281-283, 1993